Literature DB >> 8923318

How does residual water affect the solid-state degradation of drugs in the amorphous state?

E Y Shalaev1, G Zografi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8923318     DOI： 10.1021/js960257o

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  24 in total

1.  Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry.

Authors:  G M Venkatesh; M E Barnett; C Owusu-Fordjour; M Galop
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  Development of a mathematical model for the water distribution in freeze-dried solids.

Authors:  H K Chan; K L Au-Yeung; I Gonda
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

3.  Temperature dependence of bimolecular reactions associated with molecular mobility in lyophilized formulations.

Authors:  S Yoshioka; Y Aso; S Kojima
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

4.  A practical method to predict physical stability of amorphous solid dispersions.

Authors:  Stéphanie Greco; Jean-René Authelin; Caroline Leveder; Audrey Segalini
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

Review 5.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

6.  Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sources.

Authors:  David Awotwe-Otoo; Cyrus Agarabi; David Keire; Sau Lee; Andre Raw; Lawrence Yu; Muhammad J Habib; Mansoor A Khan; Rakhi B Shah
Journal:  AAPS J       Date:  2012-06-08       Impact factor: 4.009

7.  Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 2: Safety considerations of impurities in pharmaceutical products and surveying the impurity landscape.

Authors:  Karen M Alsante; Kim C Huynh-Ba; Steven W Baertschi; Robert A Reed; Margaret S Landis; Scott Furness; Bernard Olsen; Mark Mowery; Karen Russo; Robert Iser; Gregory A Stephenson; Patrick Jansen
Journal:  AAPS PharmSciTech       Date:  2013-12-21       Impact factor: 3.246

8.  An efficient method for long-term room temperature storage of RNA.

Authors:  Anne-Lise Fabre; Marthe Colotte; Aurélie Luis; Sophie Tuffet; Jacques Bonnet
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

9.  Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.

Authors:  Tobias Wm Keil; Christoph Zimmermann; Domizia Baldassi; Friederike Adams; Wolfgang Friess; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2021-05-07

10.  Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.

Authors:  Wenjin Cao; Yong Xie; Sampathkumar Krishnan; Hong Lin; Margaret Ricci
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.